Intensity Therapeutics Reports INVINCIBLE-4, Presurgical Triple-Negative Breast Cancer Study Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/16/2026

1. AMAT
2. GLOB
3. SPY
4. RDDT
5. HTFL
6. SNDK
7. WDAY
8. ADYEN:NA
9. DVLT
10. ADYYF

Go back to Intensity Therapeutics Reports INVINCIBLE-4, Presurgical Triple-Negative Breast Cancer Study Update
(NASDAQ: INTS) Delayed: 3.96 -0.04 (1%)
Previous Close $4.00    52 Week High $ 
Open $4.01    52 Week Low $ 
Day High $4.19    P/E N/A 
Day Low $3.90    EPS $ 
Volume 38,950